RadNet EBITDA 2010-2024 | RDNT

RadNet annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • RadNet EBITDA for the quarter ending September 30, 2024 was $0.086B, a 7.4% decline year-over-year.
  • RadNet EBITDA for the twelve months ending September 30, 2024 was $0.310B, a 5.56% increase year-over-year.
  • RadNet 2023 annual EBITDA was $0.295B, a 24.12% increase from 2022.
  • RadNet 2022 annual EBITDA was $0.237B, a 8.72% decline from 2021.
  • RadNet 2021 annual EBITDA was $0.26B, a 31.23% increase from 2020.
RadNet Annual EBITDA
(Millions of US $)
2023 $295
2022 $237
2021 $260
2020 $198
2019 $222
2018 $108
2017 $120
2016 $110
2015 $105
2014 $118
2013 $107
2012 $111
2011 $115
2010 $101
2009 $106
RadNet Quarterly EBITDA
(Millions of US $)
2024-09-30 $86
2024-06-30 $92
2024-03-31 $60
2023-12-31 $72
2023-09-30 $93
2023-06-30 $74
2023-03-31 $55
2022-12-31 $71
2022-09-30 $55
2022-06-30 $67
2022-03-31 $44
2021-12-31 $50
2021-09-30 $78
2021-06-30 $72
2021-03-31 $60
2020-12-31 $63
2020-09-30 $64
2020-06-30 $40
2020-03-31 $31
2019-12-31 $62
2019-09-30 $55
2019-06-30 $60
2019-03-31 $44
2018-12-31 $20
2018-09-30 $35
2018-06-30 $35
2018-03-31 $18
2017-12-31 $36
2017-09-30 $29
2017-06-30 $32
2017-03-31 $24
2016-12-31 $33
2016-09-30 $31
2016-06-30 $25
2016-03-31 $21
2015-12-31 $29
2015-09-30 $33
2015-06-30 $29
2015-03-31 $15
2014-12-31 $30
2014-09-30 $31
2014-06-30 $34
2014-03-31 $23
2013-12-31 $27
2013-09-30 $26
2013-06-30 $30
2013-03-31 $24
2012-12-31 $23
2012-09-30 $29
2012-06-30 $32
2012-03-31 $28
2011-12-31 $32
2011-09-30 $27
2011-06-30 $32
2011-03-31 $24
2010-12-31 $31
2010-09-30 $26
2010-06-30 $26
2010-03-31 $19
2009-12-31 $37
2009-09-30 $23
2009-06-30 $23
2009-03-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.911B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00